In glioma models, KEAP1 knockout significantly enhances tumor cell ferroptosis resistance through NRF2–SLC7A11 axis activation [411], molecularly elucidating the tumor‐suppressive mechanisms of KEAP1. Here, KEAP1 is linked to glioma.